Robin Ali, Ph.D., a pioneer in the use of gene therapy and stem cells to restore damaged retinas, will speak in Ann Arbor on Nov. 5.
Click here for details.
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features several interviews with Taubman Institute Director Eva Feldman, M.D., Ph.D.
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.
Taubman Scholar Dr. Charles Burant tests promising diabetes drug
TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.
Taubman Institute leaders make the case for more doctor-scientist funding
The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.
The article explores the problematic gap between bench research and clinical application of new treatments or cures.
Help Us Make A Difference. Make A Gift.
Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.
Meet the Scientific Advisory Board